Zobrazeno 1 - 10
of 450
pro vyhledávání: '"Haaijer-Ruskamp Flora M"'
Publikováno v:
Trials, Vol 13, Iss 1, p 219 (2012)
Abstract Background To improve risk factor management in diabetes, we need to support effective interactions between patients and healthcare providers. Our aim is to develop and evaluate a treatment decision aid that offers personalised information o
Externí odkaz:
https://doaj.org/article/bb4ce30e41a84fb49b410a1bbe704697
Publikováno v:
BMC Health Services Research, Vol 12, Iss 1, p 191 (2012)
Abstract Background Information on prescribing quality of diabetes care is required by health care providers, insurance companies, policy makers, and the public. Knowledge regarding the opinions and preferences of all involved parties regarding presc
Externí odkaz:
https://doaj.org/article/ce0d035f731a44feaa889cae2951d317
Publikováno v:
Health and Quality of Life Outcomes, Vol 9, Iss 1, p 83 (2011)
Abstract Clinical drug trials are often conducted in selective patient populations, with relatively small numbers of patients, and a short duration of follow-up. Observational studies are therefore important for collecting additional information on a
Externí odkaz:
https://doaj.org/article/24afa7f77529456abc73d64f5c64f5ce
Publikováno v:
BMC Health Services Research, Vol 10, Iss 1, p 137 (2010)
Abstract Background Information on prescribing quality is increasingly used by policy makers, insurance companies and health care providers. For reliable assessment of prescribing quality it is important to correctly identify the patients eligible fo
Externí odkaz:
https://doaj.org/article/cf28733374024663a4c1be0645ef23ff
Autor:
Kelen Greta, Cohen Joachim, Hofstede Geert, Lundborg Cecilia, Grigoryan Larissa, Deschepper Reginald, Deliens Luc, Haaijer-Ruskamp Flora M
Publikováno v:
BMC Health Services Research, Vol 8, Iss 1, p 123 (2008)
Abstract Background Antibiotics are widely-used medicines for which a more prudent use has been advocated to minimize development of resistance. There are considerable cross-national differences that can only partially be explained by epidemiological
Externí odkaz:
https://doaj.org/article/05cebfc877c54a078c49c74c2821bc81
Publikováno v:
Cardiovascular Diabetology, Vol 6, Iss 1, p 25 (2007)
Abstract Background Lack of treatment initiation or intensification might explain why some patients with type 2 diabetes do not reach target goals. The objective is to assess trends in risk factor treatment, and identify determinants for medication a
Externí odkaz:
https://doaj.org/article/42deb3aae1ea4d86b54bb36429fea66a
Publikováno v:
BMC Health Services Research, Vol 5, Iss 1, p 57 (2005)
Abstract Background Major international differences in heart failure treatment have been repeatedly described, but the reasons for these differences remain unclear. National guideline recommendations might be a relevant factor. This study, therefore,
Externí odkaz:
https://doaj.org/article/6a34e0dbdcd94cc6bbe9b06f03f18c56
Publikováno v:
BMC Family Practice, Vol 6, Iss 1, p 19 (2005)
Abstract Background The aim of this study is to determine to what extent barriers perceived by general practitioners (GPs) for prescribing angiotensin-converting enzyme inhibitors (ACE-I) in chronic heart failure (CHF) patients are related to underus
Externí odkaz:
https://doaj.org/article/e4485d6b9ae147b99983c81e32f6dcfa
Autor:
de Vries, Sieta T., Keers, Joost C., Visser, Rosalie, de Zeeuw, Dick, Haaijer-Ruskamp, Flora M., Voorham, Jaco, Denig, Petra
Publikováno v:
In Journal of Psychosomatic Research February 2014 76(2):134-138
Publikováno v:
Quality of Life Research, 2014 Nov 01. 23(9), 2439-2445.
Externí odkaz:
https://www.jstor.org/stable/24728022